Cox-2’s (and Pfizer?) on Slippery Slope

The FDA has just hammered Pfizer's Bextra and Celerex as well as other NSAIDs (see "FDA Announces Series of Changes to the Class of...

“Bioshield” Boondoggle

Whole industries have sprung up based upon our fear of terrorism. And it's being funded in large part by the U.S. government to the...

Separation of Church and State

The pharmaceutical industry should not be caught undermining the 'Chinese wall' between editorial content and advertising that reputable media take pains to maintain. Especially considering that the pharma industry itself has been accused of a less than stellar record of maintaining separation between education and promotion to physicians and consumers.

Straight-Talking DTC

Johnson & Johnson is unveiling a new approach to TV and print campaigns that deals head-on with safety, putting drug risks on more-equal footing with drug benefits. This article summarizes the results of a survey about whether or not the rest of the pharma industry should follow J&J's lead.

Growing Pharmaceutical Sales Utilizing Six Sigma and Lean

Six Sigma and Lean have been used for more than two decades to improve manufacturing operations in every industry around the world. This interview with an industry expert offers insights on how Six Sigma and Lean principles can be applied to improve efficiencies in pharmaceutical sales and marketing.

Beyond the eDetail: Evolving to Educate

This article reviews Lathian Systems' online solutions that are designed to help pharma companies capture the interest, gain the access, and obtain the time required to deliver effective educational programs to physicians.

Measuring Marketing Strategy

This article reviews Q2 Audit, a new company and an industry-standard measure of marketing effectiveness.

Email Marketing Best Practices for Pharma

Several recent surveys indicate that pharmaceutical companies will spend more money on e-mail marketing to consumers in 2005. Perhaps they should also spend some money and time to ensure that their email campaigns adhere to emerging best practices with regard to privacy, HIPAA, SPAM, and permission-based marketing.

Give Docs What They Want

What if pharmaceutical companies actually listened to these physicians? Instead of talking about gaining physician access by sales reps, pharmaceutical companies might provide more access to the kind of representative physicians seem to want -- the medical science liaison or MSL.

John Mack Rebuffs Merck’s CEO Offer

Sources close to the situation say that John Mack, the 48-year-old President of VirSci Corporation and publisher of Pharma Marketing News, rebuffed...